I missed the AGM today for the first time in many years, but hooked in online.
I almost can't believe the lack of questions given previous meeting as a guide. I was certain someone would raise the undisclosed conditions and why they remain a "secret" and wish I'd submitted the question.
We've seen how severely shorted the company's shares have been over recent times and since the Culper Report in particular. Surely Neuren is exposing itself to a similar scenario in providing an opportunity for someone aligned with the shorters to publish a note along the lines of - the reason Neuren hasn't released these pre-clinical results is because they weren't as good as expected.
Puzzled shareholder.
NEU Price at posting:
$13.65 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)